Evidence map›Paper›PMID 40872279›Full record

ArticlePathogens (Basel, Switzerland)2025

Prevalence of Anti-

María P de la Hoz-Martín, Juan González-Fernández, Juan Carlos Andreu-Ballester, Marte L Hoivik, Petr Ricanek, Torunn Bruland, Arne K Sandvik, Carmen Cuéllar, Ignacio Catalán-Serra

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Anisakiasis: A Decade of Molecular and Diagnostic Advancements (2015-2026).International journal of molecular sciences · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

María P de la Hoz-MartínUnidad de Parasitología, Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, Spain.
Juan González-FernándezUnidad de Parasitología, Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, Spain.ORCID 0000-0002-0306-8399
Juan Carlos Andreu-BallesterFundación FISABIO-Salud Pública de Valencia, 46020 Valencia, Spain.ORCID 0000-0003-3790-3054
Marte L HoivikDepartment of Gastroenterology, Oslo University Hospital, 0424 Oslo, Norway.
Petr RicanekDepartment of Gastroenterology, Division of Medicine, Akershus University Hospital, Lørenskog, and University of Oslo, 1478 Oslo, Norway.
Torunn BrulandDepartment of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway.ORCID 0000-0002-1568-2476
Arne K SandvikDepartment of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway.
Carmen CuéllarUnidad de Parasitología, Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, Spain.ORCID 0000-0001-7948-9889
Ignacio Catalán-SerraDepartment of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway.ORCID 0000-0001-9619-7634

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study assessed the seroprevalence of anti-

Indexed as

AnisakiasisAnisakisAntibodies, HelminthInflammatory Bowel DiseasesAdultAgedAnimalsColitis, UlcerativeCrohn DiseaseFemaleHumansImmunoglobulin AImmunoglobulin EImmunoglobulin GMaleMiddle AgedAntibodies, HelminthImmunoglobulin AImmunoglobulin EImmunoglobulin GAnisakis simplexCrohn’s diseaseinflammatory bowel diseaseulcerative colitis

Identifiers

PMID40872279
PMCPMC12388958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.